Abstract:Bacterial infectious diseases seriously threaten public health and life. The specific interaction between an antibody and its multivalent antigen is an attractive way to defeat infectious disease. However, due to the high expense and strict storage and applied conditions for antibodies, it is highly desirable but remains an urgent challenge for disease diagnosis and treatment to construct artificial antibodies with strong stability and binding ability and excellent selectivity. Herein, we designed and synthesized antibody-like bio-orthogonal catalysts with the ability to recognize specific bacteria and accomplish in situ drug synthesis in captured bacteria by using improved bacterial imprinting technology. On one hand, the artificial antibody possesses a matching morphology for binding pathogens, and on the other hand, it acts as a bio-orthogonal catalyst for in situ synthesis of antibacterial drugs in live bacteria. Both in vitro and in vivo experiments have demonstrated that our designed antibody can distinguish and selectively bind to specific pathogens and eliminate them on site with the activated drugs. Therefore, our work provides a strategy for designing artificial antibodies with bio-orthogonal catalytic activity and may broaden the application of bio-orthogonal chemistry.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c03387.Materials, measurements, experimental details of antibacterial experiments and in vivo experiment, histology, zeta potentials, SEM images, TEM images and corresponding elemental mappings, click reaction of 3-azido-7-hydroxycoumarin 1 and phenylacetylene 2, synthetic route of precursor molecules 4 and 5 and compound 6, 1H NMR, liquid chromatography–mass spectrometry analysis, and in vivo antibacterial activity against E. coli, Figure S1–S47. (PDF)This article has not yet been cited by other publications.

Artificial Antibody Created by Conformational Reconstruction of the Complementary-Determining Region on Gold Nanoparticles.

Folding of Flexible Protein Fragments and Design of Nanoparticle-Based Artificial Antibody Targeting Lysozyme.

Characterization of the Specific Interactions Between Nanoparticles and Proteins at Residue-Resolution by Alanine Scanning Mutagenesis.

Conformationally Engineering Flexible Peptides on Silver Nanoparticles.

Designed proteins assemble antibodies into modular nanocages

Construction of Antibody-Like Nanoparticles for Selective Protein Sequestration in Living Cells.

Computational design of non-porous pH-responsive antibody nanoparticles

Construction of Specific and Reversible Nanoreceptors for Proteins Via Sequential Surface-Imprinting Strategy.

Covalent and Oriented Immobilization of Scfv Antibody Fragments Via an Engineered Glycan Moiety

Antibody Mimics as Bio-orthogonal Catalysts for Highly Selective Bacterial Recognition and Antimicrobial Therapy

Atomically accurate de novo design of single-domain antibodies

Versatile and Robust method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency

Nanografting De Novo Proteins Onto Gold Surfaces.

Supramolecular Mimotope Peptide Nanofibers Promote Antibody-Ligand Polyvalent and Instantaneous Recognition for Biopharmaceutical Analysis

Computational Design of an Epitope-Specific Keap1 Binding Antibody Using Hotspot Residues Grafting and CDR Loop Swapping

A Single-Step Chemoenzymatic Reaction for the Construction of Antibody-Cell Conjugates

Nanobody Engineering: Computational Modelling and Design for Biomedical and Therapeutic Applications

Single Molecule Force Spectroscopy to Compare Natural versus Artificial Antibody-Antigen Interaction.

Precision Modification of Native Antibodies

Antibody Nanotweezer Constructing Bivalent Transistor-Biomolecule Interface with Spatial Tolerance